Antibiotics

KAW comments to FDA re distillers grains

KAW comments to FDA docket regarding the use of distillers grains as animal feed.

Comment to FDA on Food Additive Petition for Erythromycin Thiocyanate (Animal Use)

Comments to the FDA regarding the North American Bioproducts Corp. (NABC) Food Additive Petition for Erythromycin Thiocyanate (Animal Use) and recommending that the FDA not approve the addition of the critically important human drug erythromycin to animal feed due to the risk to public health from the development of antimicrobial resistance.  

FDA letter from Minnesota coops on arsenic and animal feed

A letter from food cooperatives in Minnesota to the Food and Drug Administration (FDA) in support of the legal petition by IATP and Center for Food Safety to FDA to withdraw support for the use of arsenic in animal feed.  

Overuse Of Antibiotics on the Farm and the Effect on Human Health Highlight Informational Briefings in Senate, House

Infectious disease doctors, public health experts and scientific researchers met with Congressional leaders and staff on Wednesday to describe how the routine non-therapeutic use of human antibiotics in the food and water of livestock results in antibiotic-resistant diseases in humans that cause extended hospital stays and increase health care costs.

KAW written testimony to House Committee on Appropriations Subcommittee requesting new appropriations for antibiotics

KAW written testimony to House Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Over 100 organizations signed on requesting that as part of the fiscal year 2011 appropriations, three appropriations should be included that will help research, monitor, and find solutions to the problem of antibiotic resistance.

KAW letter to FDA re: growth promoter ban

KAW letter to FDA critiquing a possible growth promoter only ban in the United States.

Impact of Growth Promoter Only Ban

KAW analysis of the impact of a growth promoter only ban in the United States which are classified as critically important classes under FDA Guidance #152.  

KAW comments to FDA on ADUFA data collection

KAW comments to FDA docket on ADUFA data collection.

While FDA fiddles, dangerous antibiotic-resistant Salmonella strikes again

 KAW press release on resistant Salmonella outbreaks A recent outbreak of beef-borne Salmonella Newport in Colorado and other Western states was caused by a microbe resistant to cephalosporin antibiotics. These antibiotics continue to be used “off label” a year after the Bush Administration’s Food and Drug Administration tabled plans to ban this use

Antibiotics, Animal Agriculture and MRSA: A New Threat

Widespread use of antibiotics leads to the development and spread of more antibiotic-resistant bacteria, like MRSA. When used, antibiotics kill off susceptible bacteria leaving resistant ones to multiply and spread; greater use of antibiotics—wherever that occurs—translates into greater numbers and different varieties of drug-resistant bacteria.